ACOG supports prohibiting insurers from using a pre-existing condition exclusion to deny health-care coverage.
The American College of Obstetricians and Gynecologists (ACOG) has declared support for legislation that would prohibit insurers from using a pre-existing condition exclusion to deny health-care coverage based on past or present health status. The ban would apply to pregnant women as well as to survivors of domestic violence and patients with cancer. According to ACOG Legislative and Policy News (6/12/09), ACOG President Gerald F. Joseph, MD, has pointed out that "...insurers can often impose a waiting period for maternity services, sometimes for 9 months, delaying vital care."
The Pre-existing Condition Patient Protection Act of 2009, H.R. 1558/S.623, was introduced by Senator John D. Rockefeller, IV (D-WV) on March 17, 2009 and has five cosponsors. It prohibits a group health plan from imposing any preexisting condition exclusion or providing for an affiliation period-the period of time before health insurance coverage becomes effective-for coverage offered by a health maintenance organization.
The bill has been referred to the Senate committee on health, education, labor, and pensions.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More